Electronic symptom monitoring with patient-reported outcomes (PRO) meaningfully improves clinical outcomes for cancer treatment.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified ...

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.